Skip to main navigation Skip to search Skip to main content

Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study

  • E M H Schmitz
  • , S Benoy-De Keuster
  • , A J L Meier
  • , V Scharnhorst
  • , R A M Traksel
  • , M A C Broeren
  • , L J J Derijks

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology